Uutiset

Press Release – medac Diagnostics: a complete package for COVID-19 testing

08.05.2020 With immediate effect: 3 million proven antibody tests for SARS-CoV-2 and mastermix ready-to use PCR tests. 17 million more antibody tests available.  

Press Release – medac Diagnostics Portfolio

08.05.2020 With immediate effect: medac´s proven methods for SARS-CoV-2 testing for the German-speaking world

Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis

Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release

Press release – Results of phase III study with Treosulfan, EMA approval pending

Highly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS and AML Click here to view full Press release  

Press release – Medac Finland – 10-years anniversary symposium

Enhancing the potential of methotrexate. Optimise  rheumatism  treatment  in  Finland  with  Metoject®   PEN   and ensure long-term success of therapy Helsinki / Wedel (September 21, 2017). There is room for improvement in drug treatment of rheumatoid arthritis (RA) with the gold standard methotrexate (MTX). Current analyses of the FIN-ERA cohort suggest that Finnish rheumatology exploits the […]